Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of critical SARS-CoV-2 infection in hospitalized patients with COVID-19: a randomized, parallel-group, openlabel, multi-center exploratory trial. NFP 78
Research Project | 01.08.2020 - 31.01.2022
|
01.08.2020
- 31.01.2022
Funding
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of critical SARS-CoV-2 infection in hospitalized patients with COVID-19: a randomized, parallel-group, openlabel, multi-center exploratory trial. NFP 78
SNF Projekt (GrantsTool), 08.2020-01.2022 (18)
PI : Osthoff, Michael.
Members (1)
